Literature DB >> 22718509

Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.

Wei-Wei Chang1, Liu Zhang, Ying-Shui Yao, Hong Su.   

Abstract

The results of studies on association between CTLA-4 exon-1 +49A/G (rs231775) polymorphism and susceptibility to systemic lupus erythematosus are controversial. To derive a more precise estimation of the relationship between the CTLA-4 exon-1 +49A/G polymorphism and SLE, a meta-analysis of 18 published case-control studies was performed. 18 studies meeting our inclusion criteria comprising 1806 SLE cases and 2,490 controls were included. The effect summary odds ratio (OR) and 95 % confidence intervals were obtained. Publication bias was tested by funnel plot, Egger's test and heterogeneity was assessed. The combined results showed that there were significant differences in genotype distribution between SLE cases and control on the basis of all studies, GG versus AA (OR = 1.53, 95 % CI: 1.12-2.10), GG versus GA/AA (OR = 1.30, 95 % CI: 1.04-1.64), GG versus GA (OR = 1.27, 95 % CI: 1.03-1.55). When stratifying for the race, the phenomenon was found that SLE cases had a significantly higher frequency of GG/GA versus AA (OR = 1.58, 95 % CI: 1.23-2.03), GG versus AA (OR = 1.89, 95 % CI: 1.23-2.91), GG versus GA/AA(OR = 1.39, 95 % CI: 1.03-1.89), GA versus AA(OR = 1.38, 95 % CI: 1.06-1.80) and G versus A(OR = 1.34, 95 % CI: 1.07-1.67) than control in Asians. Our meta-analysis results suggest that CTLA-4 exon-1 +49A/G polymorphism might be a risk factor for SLE susceptibility, at least in Asians. The large sample and well-designed study based on different ethnic groups should be considered in future associated studies to clarify the association of CTLA-4 exon-1 +49A/G polymorphism with SLE susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718509     DOI: 10.1007/s11033-012-1788-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus.

Authors:  J Heward; C Gordon; A Allahabadia; A H Barnett; J A Franklyn; S C Gough
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

2.  The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.

Authors:  Todd N Eagar; Nitin J Karandikar; Jeffrey A Bluestone; Stephen D Miller
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

5.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

6.  CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Hum Genet       Date:  2005-02-02       Impact factor: 4.132

7.  Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

Authors:  Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Yao-Hsu Yang; Dong-Tsamn Lin; Bor-Luen Chiang
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

8.  Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia.

Authors:  Kek-Heng Chua; Suat-Moi Puah; Ching-Hoong Chew; Si-Yen Tan; Lay-Hoong Lian
Journal:  Ann Hum Biol       Date:  2010-04       Impact factor: 1.533

9.  Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.

Authors:  Marta Barreto; Eugénia Santos; Ricardo Ferreira; Constantin Fesel; Maria Francisca Fontes; Clara Pereira; Berta Martins; Rita Andreia; João Faro Viana; Francisco Crespo; Carlos Vasconcelos; Carlos Ferreira; Astrid Moura Vicente
Journal:  Eur J Hum Genet       Date:  2004-08       Impact factor: 4.246

10.  CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus.

Authors:  Francisco Aguilar; Belén Torres; Julio Sánchez-Román; Antonio Núñez-Roldán; María Francisca González-Escribano
Journal:  Hum Immunol       Date:  2003-10       Impact factor: 2.850

View more
  5 in total

1.  Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?

Authors:  Lidia Karabon; K Tupikowski; A Tomkiewicz; A Partyka; E Pawlak-Adamska; A Wojciechowski; A Kolodziej; J Dembowski; R Zdrojowy; I Frydecka
Journal:  Pathol Oncol Res       Date:  2017-01-18       Impact factor: 3.201

2.  Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.

Authors:  Suad AlFadhli
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

3.  Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.

Authors:  Hai-Feng Li; Yu Hong; Xu Zhang; Yanchen Xie; Geir Olve Skeie; Hong-Jun Hao; Nils Erik Gilhus; Bing Liang; Yao-Xian Yue; Xian-Jun Zhang; Xiang Gao; Qi Wang; Zhe Gao; Xiao-Jun Ding; Min Song
Journal:  Mol Neurobiol       Date:  2016-08-08       Impact factor: 5.590

Review 4.  Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

Authors:  Sherry-Ann Brown; Jordan C Ray; Joerg Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2020-04-06       Impact factor: 4.132

5.  Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Authors:  Bridget Charbonneau; Kirsten B Moysich; Kimberly R Kalli; Ann L Oberg; Robert A Vierkant; Zachary C Fogarty; Matthew S Block; Matthew J Maurer; Krista M Goergen; Brooke L Fridley; Julie M Cunningham; David N Rider; Claudia Preston; Lynn C Hartmann; Kate Lawrenson; Chen Wang; Jonathan Tyrer; Honglin Song; Anna deFazio; Sharon E Johnatty; Jennifer A Doherty; Catherine M Phelan; Thomas A Sellers; Starr M Ramirez; Allison F Vitonis; Kathryn L Terry; David Van Den Berg; Malcolm C Pike; Anna H Wu; Andrew Berchuck; Aleksandra Gentry-Maharaj; Susan J Ramus; Brenda Diergaarde; Howard Shen; Allan Jensen; Janusz Menkiszak; Cezary Cybulski; Jan Lubiłski; Argyrios Ziogas; Joseph H Rothstein; Valerie McGuire; Weiva Sieh; Jenny Lester; Christine Walsh; Ignace Vergote; Sandrina Lambrechts; Evelyn Despierre; Montserrat Garcia-Closas; Hannah Yang; Louise A Brinton; Beata Spiewankiewicz; Iwona K Rzepecka; Agnieszka Dansonka-Mieszkowska; Petra Seibold; Anja Rudolph; Lisa E Paddock; Irene Orlow; Lene Lundvall; Sara H Olson; Claus K Hogdall; Ira Schwaab; Andreas du Bois; Philipp Harter; James M Flanagan; Robert Brown; James Paul; Arif B Ekici; Matthias W Beckmann; Alexander Hein; Diana Eccles; Galina Lurie; Laura E Hays; Yukie T Bean; Tanja Pejovic; Marc T Goodman; Ian Campbell; Peter A Fasching; Gottfried Konecny; Stanley B Kaye; Florian Heitz; Estrid Hogdall; Elisa V Bandera; Jenny Chang-Claude; Jolanta Kupryjanczyk; Nicolas Wentzensen; Diether Lambrechts; Beth Y Karlan; Alice S Whittemore; Hoda Anton Culver; Jacek Gronwald; Douglas A Levine; Susanne K Kjaer; Usha Menon; Joellen M Schildkraut; Celeste Leigh Pearce; Daniel W Cramer; Mary Anne Rossing; Georgia Chenevix-Trench; Paul D P Pharoah; Simon A Gayther; Roberta B Ness; Kunle Odunsi; Lara E Sucheston; Keith L Knutson; Ellen L Goode
Journal:  Cancer Immunol Res       Date:  2014-01-27       Impact factor: 11.151

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.